Jawline Filler: Cost, Results and Candidates

Jawline filler is a soft-tissue filler injected along the jawline — under the skin or, with both approved products, just above the jawbone — to improve jawline definition and contour.

Two US products are approved for that use. Juvéderm Volux XC was FDA-approved on 2022-07-29 for subcutaneous and/or supraperiosteal injection to improve jawline definition in adults over 21 with moderate to severe loss of jawline definition.

Radiesse (+), the lidocaine version of Merz's calcium hydroxylapatite implant, was approved on 2021-09-01 for deep (subdermal and/or supraperiosteal) injection to improve moderate to severe loss of jawline contour in adults over 21.

The most direct jawline evidence is Volux's US randomized study.

At month 6, 69.0% of treated participants (n=157) had improved at least one grade on the study's jawline-definition scale, versus 38.0% of controls (n=49), and the authors report effectiveness through 1 year.

Most injection-site responses were mild or moderate and resolved within 2 weeks.

These are trial results for the product studied, not a prediction of what any one person will see.

The material matters for what follows.

Radiesse is not a hyaluronic acid gel — it is an injectable implant of synthetic calcium hydroxylapatite (CaHA) particles suspended in a gel carrier, which is why ASPS counts it among non-HA fillers and why, unlike Volux, it does not dissolve with hyaluronidase, which Cleveland Clinic says works only on hyaluronic acid fillers.

As of 2026-10-20, exactly two US fillers carry an FDA-approved jawline indication: Juvéderm Volux XC and Radiesse (+).

Any other filler injected for jawline shape is being used off-label — it is not on any current US label for that product.

Volux XC (Allergan) is the newer of the two, approved on 2022-07-29, and it is the only hyaluronic acid filler with a jawline indication.

Radiesse (+) is Merz's product: synthetic CaHA particles in a gel carrier, with the jawline indication held by the (+) lidocaine formulation specifically.

Restylane Lyft is not one of them.

Galderma's Lyft is FDA-approved for moderate to severe facial folds such as nasolabial folds, for cheek augmentation and age-related midface contour deficiencies (2015), for volume deficit in the back of the hands (2018) and, since 2025-11-04, for chin augmentation in mild to moderate chin retrusion — not for the jawline.

Sculptra has no jawline indication either.

Galderma's site cites an 86% improved-jawline-contour figure at 2 years from a study that ended at 96 weeks; the figure is a marketing claim — jawline is not an FDA-approved Sculptra use.

Keep jawline filler separate from chin filler, too: three other fillers hold chin indications — Juvéderm Voluma XC (2020), Restylane Defyne (2021) and Restylane Lyft (2025) — which is why chin retrusion and jawline definition are different questions with different approved products.

Jawline filler is priced by the amount used — effectively per syringe — and the price moves with the product, the provider and how much definition a face needs.

Allergan's Juvéderm FAQ does not publish a price; it says pricing varies by the product, the amount used and the provider.

The trial numbers give scale, not a dose.

In the Volux jawline study, the protocol allowed up to 8.0 mL in total across both sides (initial treatment plus touch-up), and participants averaged about 6 mL across up to 9 sites — chin, pre-jowl, post-jowl, marionette lines and jaw angles.

The authors themselves note that is more than would likely be administered in clinical practice.

We found no confirmed national jawline-filler price to quote.

The closest figures are ASPS's averages — $715 for hyaluronic acid fillers and $901 for non-HA fillers such as Radiesse and Sculptra — which are physician-fee averages for fillers of that type generally, not med spa prices and not jawline-specific numbers.

One money note: Allergan's Allē program lists Juvéderm at 200 points per syringe, and every 100 points is worth $10 toward qualifying treatments (rates as read on 2026-10-16).

Ask any provider you are considering for a per-syringe quote in writing before you book.

The FDA approvals do not split by sex: both Volux XC and Radiesse (+) are approved for adults over 21 with moderate to severe loss of jawline definition or contour, and nothing in the indications is written separately for men.

Juvéderm's ISI adds two candidacy limits worth knowing either way: Volux XC safety was not studied in patients under 22, and Voluma XC was not studied in people with significant loose skin of the chin, neck or jaw.

We could not confirm jawline-filler results reported separately for men — the published Volux trial figures on this page are not broken out by sex in the sources we reviewed.

A licensed provider can show you before-and-after photos of cases similar to yours and talk through what a defined-jaw look would involve for your anatomy.

The clearest jawline figure is Allergan's own: it says Juvéderm Volux XC provides jawline results that can last up to 1 year with optimal treatment.

The words doing the work there are "up to." Allergan's duration list — Voluma XC cheeks up to 2 years, Voluma XC chin up to 1 year, temples up to 13 months, Volbella XC under-eyes up to 1 year, Volux XC jawline up to 1 year — is entirely phrased "with optimal treatment," which often includes touch-ups.

None of these figures is a typical-result promise.

The trial gives the same horizon without the marketing framing: the Volux study authors report effectiveness through 1 year, with 69.0% of treated participants improved at month 6.

For Radiesse, Merz says results have been shown to last up to 2 years, citing a 2010 study, while its own safety statement says it is not known whether Radiesse is safe or effective beyond 3 years in the face.

Both figures are for the product generally, not a jawline-specific duration.

Side effects run on a shorter clock than results.

In Allergan's study, the most common Volux side effects — tenderness, lumps/bumps, pain, swelling, firmness, bruising, redness, itching and discoloration — were mild or moderate and lasted 14 days or less.

Merz lists bruising, redness, swelling, pain and itching as common Radiesse side effects, and its face studies of Radiesse (+) also reported difficulty chewing.

The three treatments act on different tissue.

Jawline filler adds volume along the jaw border. Kybella is a prescription drug whose label describes it as physically destroying fat-cell membranes — FDA-approved only for improving the appearance of moderate to severe fullness associated with submental (under-chin) fat in adults.

Botulinum toxin injected into the masseter muscle for jaw slimming — masseter Botox — acts on muscle instead.

That makes Kybella a poor match for the jawline in approval terms: it is not approved for fat outside the under-chin region, and its label says such use is not recommended — jawline and jowl use is off-label.

Masseter Botox is off-label as well: no US toxin label includes the masseter, though AbbVie has run phase 2 and phase 3 trials of Botox for masseter prominence.

Which treatment fits — volume, fat or muscle — is a question for a licensed provider who examines the lower face.

Because only two products are approved for this area, the first question for any provider is which filler they plan to use and whether the jawline is an approved use for it.

The second is the price per syringe, in writing.

Setting matters.

The American Academy of Dermatology says never get filler injections at a non-medical spa, a party, a salon or someone's home.

Those five questions come from the American Academy of Dermatology's list of what to ask before a cosmetic procedure.

AmSpa, the med spa trade association, says injecting a prescription drug such as botulinum toxin is the practice of medicine, so it must be done by a physician, an independent-practice nurse practitioner, or another licensed professional acting within their scope, under rules that vary by state.

For filler, ask who will inject you and what that person's license is, and check the answers against the rules where you live.

Our state med spa laws guide covers who may inject where, and our injector credentials guide explains the licenses and titles you will see.